Finbarr P M O'Harte Selected Research

Blood Glucose (Blood Sugar)

1/2018

Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Finbarr P M O'Harte Research Topics

Disease

20	Type 2 Diabetes Mellitus (MODY) 09/2023 - 02/2002
18	Obesity 09/2023 - 04/2002
18	Body Weight (Weight, Body) 08/2022 - 09/2004
17	Insulin Resistance 08/2022 - 06/2003
2	Glucose Intolerance 01/2022 - 02/2006
1	Feeding and Eating Disorders (Eating Disorder) 09/2023
1	Anorexia 09/2023
1	Bulimia (Binge Eating) 09/2023
1	Short Bowel Syndrome 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Hyperglycemia 11/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2007
1	Overnutrition 10/2003

Drug/Important Bio-Agent (IBA)

22	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 02/2002
15	Peptides (Polypeptides)IBA 09/2023 - 08/2003
14	Insulin (Novolin)FDA Link 11/2022 - 04/2002
8	gastric inhibitory polypeptide receptorIBA 01/2022 - 02/2002
6	Glucagon (Glukagon)FDA Link 08/2022 - 12/2003
6	Glucagon-Like Peptide 1 (GLP 1)IBA 08/2022 - 02/2007
4	IncretinsIBA 01/2022 - 12/2003
4	AmidesIBA 12/2020 - 01/2018
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 09/2005
4	Hormones (Hormone)IBA 01/2018 - 10/2003
4	Pro(3)- glucose-dependent insulinotropic polypeptideIBA 02/2007 - 02/2002
3	Exenatide (Byetta)FDA Link 08/2022 - 01/2018
3	ApelinIBA 01/2020 - 12/2017
3	apelin-13 peptideIBA 01/2020 - 12/2017
3	Triglycerides (Triacylglycerol)IBA 01/2018 - 10/2009
3	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 08/2013 - 09/2005
2	Glucagon Receptors (Glucagon Receptor)IBA 08/2022 - 04/2014
2	LipidsIBA 01/2020 - 01/2018
1	GalaninIBA 09/2023
1	semaglutideIBA 01/2022
1	tirzepatideIBA 01/2022
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2022
1	Fish ProteinsIBA 11/2020
1	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Liraglutide FDA Link 01/2020
1	LDL CholesterolIBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	HDL CholesterolIBA 01/2018
1	OxyntomodulinIBA 11/2014
1	deshistidyl(1)-prolyl(4)-glutamyl(9)- glucagonIBA 10/2014
1	monomethoxypolyethylene glycol (MPEG)IBA 08/2013
1	Cholecystokinin (Pancreozymin)IBA 08/2013
1	(pGlu-Gln)-CCK-8IBA 01/2013
1	Nateglinide (Starlix)FDA LinkGeneric 12/2009
1	Dipeptidyl-Peptidase IV InhibitorsIBA 07/2007
1	SolutionsIBA 07/2007
1	Hyp(3)- glucose-dependent insulinotropic polypeptideIBA 06/2007
1	Hyp(3)-palmitoylLys(16)- glucose-dependent insulinotropic polypeptideIBA 06/2007
1	exendin (9-39)IBA 02/2007
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2006
1	N-AcGIP(LysPAL37)IBA 04/2006
1	PalmitatesIBA 02/2005
1	glycated insulinIBA 02/2003
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 04/2002
1	EnzymesIBA 02/2002

Therapy/Procedure

7	Therapeutics 01/2022 - 10/2003
4	Injections 01/2020 - 09/2005
1	Intraperitoneal Injections 02/2006